AN2 Therapeutics Inc

ANTXNASDAQ
$5.89
-0.06-1.01%
At close: Sep 4, 5:00 PM EST
$5.89
N/A
After Hours: Sep 4, 4:01 PM EST

AN2 Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for AN2 Therapeutics (ANTX).

Price Target Range — 8 Quarters

Analyst Consensus — 6 Analysts

2S.Buy
2Buy
2Hold
Consensus RatingMarket Outperform# Analysts6Avg. Consensus PT$5Upside to Avg. PT-8.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings
DateFirmAnalystActionRating ChangePrice Target
Jul 20, 2026GuggenheimBrad CaninoInitiateBuy$9
May 14, 2026Leerink PartnersJoseph SchwartzUpgradeMarket PerformOutperform$9

Analyst Ratings News